Last reviewed · How we verify
NCT06216106: IBR-PPBR
Data Collection of Prepectoral Breast Reconstruction With Polyurethane Implantes
trial testing Prepectoral breast reconstruction with polyurethane implants in Prepectoral Breast Reconstruction in 237 participants. Completed in 5 October 2023.
22 December 2022
Quick facts
| Lead sponsor | European Institute of Oncology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 237 |
| Start date | 18 March 2020 |
| Primary completion | 22 December 2022 |
| Estimated completion | 5 October 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Prepectoral breast reconstruction with polyurethane implants
Conditions studied
- Prepectoral Breast Reconstruction — all drugs for Prepectoral Breast Reconstruction →
- Breast Reconstruction — all drugs for Breast Reconstruction →
- Radiation Therapy Complication — all drugs for Radiation Therapy Complication →
Sponsor
European Institute of Oncology
Who can join
Eligibility, female only, with Prepectoral Breast Reconstruction or Breast Reconstruction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about correct surgical indications and long-term complications in patient with immediate prepectoral breast reconstruction with polyurethane implants. The main question it aims to answer are: what are the correct indications for this type of reconstruction? what is the complications rates? are the complications affected by pre and post operative radiotherapy? It's a retrospective study of all the patients that received prepectoral breast reconstruction with polyurethane implants without any exclusion factors. Researchers will compare the non-irradiated group with the patients with pre and post radiation therapy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants.
Lisa A, Riccardi F, Alessandri-Bonetti M, Mazzocconi L, et al · · 2025 · cited 1× · PMID 40695028 · DOI 10.1016/j.breast.2025.104520
Verify or expand the search:
- PubMed search for NCT06216106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prepectoral Breast Reconstruction
Currently open trials in the same condition.
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
Other European Institute of Oncology trials
Trials by the same sponsor.
- NCT07374809 — IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER · NA · not yet recruiting
- NCT07429851 — CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors · recruiting
- NCT07325864 — Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site · recruiting
- NCT07508319 — Role of the Immune System in Preventing Laryngeal Cancer · recruiting
- NCT07180693 — Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors: · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06216106 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by European Institute of Oncology
- Last refreshed: 22 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06216106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing